Glycogen synthase kinase-3 (GSK3) has been implicated in major neurological disorders, but its role in normal neuronal function is largely unknown. Here we show that GSK3b mediates an interaction between two major forms of synaptic plasticity in the brain, N-methyl-D-aspartate (NMDA) receptor-dependent long-term potentiation (LTP) and NMDA receptor-dependent long-term depression (LTD). In rat hippocampal slices, GSK3b inhibitors block the induction of LTD. Furthermore, the activity of GSK3b is enhanced during LTD via activation of PP1. Conversely, following the induction of LTP, there is inhibition of GSK3b activity. This regulation of GSK3b during LTP involves activation of NMDA receptors and the PI3K-Akt pathway and disrupts the ability of synapses to undergo LTD for up to 1 hr. We conclude that the regulation of GSK3b activity provides a powerful mechanism to preserve information encoded during LTP from erasure by subsequent LTD, perhaps thereby permitting the initial consolidation of learnt information.
INTRODUCTION
GSK3 is a multifunctional serine/threonine (ser/thr) kinase that was originally identified as a regulator of glycogen metabolism (Embi et al., 1980) . Ubiquitously expressed in eukaryotes (see Ali et al., 2001 ), GSK3 plays a fundamental role in a wide variety of functions, including the division, proliferation, differentiation, and adhesion of cells (Frame and Cohen, 2001; Grimes and Jope, 2001 ). GSK3 dysfunction is implicated in major diseases, including cancer and diabetes (Frame and Cohen, 2001) . There are two known isoforms of GSK3 in mammals that are encoded by different genes (GSK3a and GSK3b) (Woodgett, 1990) . Only GSK3b, however, is highly enriched in the brain (Leroy and Brion, 1999; Woodgett, 1990; Takahashi et al., 1994) , where it has been implicated in several central nervous system (CNS) dysfunctions, such as Alzheimer's disease (Alvarez et al., 2002; Anderton, 1999; Bhat et al., 2004; Eldar-Finkelman, 2002; Grimes and Jope, 2001) , schizophrenia (Beasley et al., 2001; EldarFinkelman, 2002; Kozlovsky et al., 2002) , and bipolar disorders (Eldar-Finkelman, 2002; Grimes and Jope, 2001; Klein and Melton, 1996) . Therefore, GSK3b is a prime drug target for a variety of CNS therapies. Nonetheless, its normal functions in the nervous system have remained largely unknown.
The GSK3b isoform is an unusual enzyme in that it has high basal activity, which is primarily determined by the phosphorylation status of ser9. The dephosphorylation of this residue by ser/thr protein phosphatases leads to further activation of GSK3b. Conversely, phosphorylation of ser9 by a variety of kinases results in inhibition of its activity. For example, in glycogen metabolism, insulin stimulates PI3K, which leads to activation of Akt (also known as protein kinase B). This then results in phosphorylation of GSK3b to inhibit its activity, allowing dephosphorylation of glycogen synthase and the stimulation of glycogen synthesis (Doble and Woodgett, 2003; Frame and Cohen, 2001) . Other upstream signaling pathways can also regulate GSK3b and, in the case of Wnt signaling, this involves direct protein:protein interactions with GBP/FRAT1 (Doble and Woodgett, 2003) . Numerous potential substrates for GSK3b have been identified, including several different transcription factors, metabolic enzymes, proteins that bind to microtubules, and components of the machinery involved in cell division and cell adhesion (Doble and Woodgett, 2003; Frame and Cohen, 2001) . Of particular relevance to neurological disorders, GSK3b has been shown to bind to and phosphorylate both presenilin-1 and tau, proteins implicated in the etiology of Alzheimer's disease Hanger et al., 1992; Kirschenbaum et al., 2001) . There are a variety of inhibitors available to address the function of GSK3b in the brain. Lithium is of particular interest, because inhibition of GSK3b may account for lithium's ability to act as a mood stabilizing drug (Klein and Melton, 1996) .
A major function of the brain is to store information. It is widely believed that most information is stored at synapses in the form of alterations in synaptic efficiency. In particular, two forms of synaptic plasticity, LTP and LTD, have been extensively investigated in the pursuit of understanding the molecular and cellular basis of learning and memory (Bliss and Collingridge, 1993; Bear and Abraham, 1996) . The dominant forms of both LTP and LTD are triggered by the synaptic activation of one class of glutamate receptor, the NMDA receptor, and are expressed as alterations in synaptic transmission mediated by another class of glutamate receptor, the a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor (Collingridge et al., 1983; Dudek and Bear, 1992; Mulkey and Malenka, 1992) . Most information has been derived from studies in the hippocampus, a brain region that is critically involved in learning and memory. It is known, for example, that during LTD the transient activation of NMDA receptors leads to internalization of AMPA receptors from the surface of the neuron (Beattie et al., 2000; Collingridge et al., 2004) . Synapses are able to undergo bidirectional plasticity, such that different patterns of synaptic activation result in NMDA receptor signals that can induce either LTP or LTD. This property is likely to be critically important in enabling the brain to store vast amounts of information (Bliss and Collingridge, 1993; Malenka and Bear, 2004) . However, it is not known whether mechanisms exist to prevent interference between LTP and LTD at synapses.
To address the normal function of GSK3b in the CNS, we have made recordings from hippocampal neurons and have discovered that various inhibitors of GSK3b completely prevent the induction of LTD. Furthermore, we describe a physiological function for the inhibition of GSK3b. Thus, we show that LTP inhibits the induction of LTD for up to an hour via activation of the PI3K-AktGSK3b pathway.
RESULTS

GSK3 Inhibitors Block the Induction of LTD
To determine whether GSK3b is involved in synaptic plasticity in the brain, we tested the effects of the highly selective GSK3 inhibitor 3-[(3-chloro-4-hydroxyphenyl)-amino]-4-(2-nitrophenyl)-1H-pyrrole-2,5-dione (SB415286) (Coghlan et al., 2000) in rat hippocampal slices. We applied SB415286 (10 mM) to the perfusing medium and used extracellular recording to investigate its effects on LTD, LTP, and the reversal of LTP by depotentiation ( Figure 1 ). SB415286 had no effect on baseline synaptic transmission (data not shown), but it blocked the induction of LTD induced by low-frequency stimulation (LFS; 900 stimuli delivered at 1 Hz; n = 9). Thus, 60 min following LFS, the slope of the field excitatory postsynaptic potential (fEPSP) of SB415286-treated slices was 103% ± 2% of baseline (n = 9) compared with 65% ± 5% (n = 3) of baseline for untreated slices (p < 0.001). In contrast, in an independent input of SB415286 treated slices, LTP was readily induced by tetanic stimulation (either one tetanus [n = 5] or four tetani delivered at 30 s intervals [n = 4]; each tetanus comprising 100 Hz stimulation for 1 s) and was reversed by depotentiation (900 stimuli delivered at 1 Hz) in each of the seven slices tested. Therefore, of the three major forms of synaptic plasticity studied, SB415286 specifically blocks the induction of LTD.
Since LTD is induced and expressed postsynaptically (Collingridge et al., 2004; Kemp and Bashir, 2001) , we infused individual CA1 pyramidal neurons in rat hippocampal slices with SB415286 via a whole-cell patch electrode to selectively block only postsynaptic GSK3b (Figure 2) . Consistent with no effect on basal synaptic transmission, excitatory postsynaptic currents (EPSCs), evoked by stimulating Schaffer collateral-commissural fibers, were similar in the presence or absence of intracellular SB415286 (10 mM). However, SB415286 blocked the induction of LTD (Figures 2B and 2D) , which was routinely induced in interleaved control neurons by delivering 300 pulses at À40 mV (Luthi et al., 1999; Figures 2A and 2C) . Thus, 20 min following this stimulation, the EPSC amplitude of the test pathway was 100% ± 3% (n = 7) and 63% ± 4% (n = 16) of baseline, for the SB415286-treated and untreated neurons, respectively (p < 0.001).
We next sought to firmly establish a role for GSK3b in LTD by further exploring the pharmacological block of LTD. We first tested SB415286 at a lower concentration and found that this inhibitor exhibited a concentrationdependent inhibition of LTD, with 3 mM producing $50% inhibition ( Figure 2H ). Although SB415286 has previously been found to be a highly selective inhibitor of GSK3b (Coghlan et al., 2000) , we wanted to rule out the possibility that it was acting through inhibition of other kinases over this concentration range. We therefore tested the effects of two other structurally unrelated GSK3b inhibitors, lithium (Klein and Melton, 1996) and kenpaullone (Leost et al., 2000) . Lithium also produced a concentrationdependent inhibition of LTD, with a partial inhibition at 2 mM and a complete block at 20 mM (Figures 2E and 2H) , while kenpaullone fully blocked LTD at a concentration of 10 mM ( Figures 2F and 2H ). GSK3b is most closely related to the cyclin-dependent protein kinases (CDKs). We therefore tested the potent CDK inhibitor roscovitine (Meijer et al., 1997) , which does not affect GSK3b (Bain et al., 2003) . This compound had no effect on LTD when applied at 10 mM ( Figures 2G and 2H ), a concentration 40 times the IC 50 for inhibition of CDK2 (Bain et al., 2003) . The ability of all three GSK3b inhibitors to prevent LTD over the concentration range at which they are inhibitors of GSK3b (Bain et al., 2003) , considered together with the insensitivity to the CDK2 inhibitor, strongly implicates a role for this enzyme in LTD.
LTD Is Associated with an Increase in GSK3b Activity
These pharmacological experiments demonstrate the requirement for GSK3b activity for the induction of LTD. To Neuron determine whether the activity of GSK3b is altered during LTD, we delivered LFS and investigated the phosphorylation status of GSK3b in the CA1 area of hippocampal slices. LTD induction was associated with a reduction in the phosphorylation of ser9 of GSK3b but no change in total GSK3b ( Figure 3A) , which corresponds to activation of the enzyme. Since Akt can phosphorylate ser9 of GSK3b, we also measured the effects of LFS on this enzyme. LFS caused a decrease in phosphorylation of thr308 of Akt, which corresponds to inhibition of this enzyme ( Figure 3A ). To confirm that LTD actually involves an alteration in GSK3b enzymatic activity, and to quantify this change, we measured the GSK3b activity of the homogenates directly using 32 P labeling of a synthetic GSK3b substrate.
After LTD induction, there was a significant increase in kinase activity above basal levels (32% ± 4%; n = 3; p < 0.05; Figure 3B ). Consistent with a role in LTD, the alteration in ser9 phosphorylation of GSK3b was prevented when LFS was delivered in the presence of the NMDA receptor antagonist 50 mM D-2-amino-5-phosphonopentanoate (D-AP5; data not shown) or 1 mM okadaic acid (n = 5, Figure 3C ), a compound that also blocks LTD via inhibition of PP1 (Mulkey et al., 1994) . Interestingly, okadaic acid also caused an increase in basal phosphorylation of GSK3b, which suggests that protein phosphatases maintain the constitutive activity of GSK3b in neurons. Okadaic acid also prevented the LFS-induced decrease in phosphorylation of Akt, but it had no effect on basal levels ( Figure 3D ). Therefore, during LTD the activation of GSK3b may be due to the phosphatase inhibiting Akt and dephosphorylating ser9 of GSK3b.
To determine whether the activation of GSK3b is transient, we measured its phosphorylation immediately and 20 min following the delivery of LFS. We also examined the effects of a tetanus (100 Hz, 1 s). LFS and tetanic stimulation caused opposite effects on the phosphorylation status of ser9 of GSK3b that were similar in magnitude at both time points (Figures 3E and 3F ). The finding that the change in GSK3b phosphorylation persisted beyond the delivery of LFS suggests that its increase in activity could be involved in the maintenance of LTD, though alternatively, it may be an epiphenomenon. To directly examine the possibility that GSK3b activity may be required beyond the delivery of LFS, we investigated the effects of its inhibition after LTD had been induced. For these experiments we used lithium, since it is rapidly membrane permeant. Lithium (20 mM) had no effect on baseline transmission but fully blocked the induction of LTD ( Figure 3G ). Interestingly, lithium was also fully effective when applied after the delivery of LFS ( Figure 3H ).
GSK3b Is Present in Dendritic Spines and Forms a Complex with AMPA Receptors
GSK3b is mainly found in the cytosol. However, our experiments predict that a fraction of GSK3b should be present in the vicinity of synapses. As shown in Figure 4A , GSK3b is distributed throughout hippocampal neurons and, to a lesser extent, throughout glial cells too. Importantly, GSK3b is present in dendritic spines. Consistent with the immunocytochemistry, western blotting revealed the Neuron presence of GSK3b in both cytosolic and synaptosomal fractions prepared from both hippocampal ( Figure 4B ) and neocortical (data not shown) slices.
NMDA receptor-dependent LTD is due to the internalization of AMPA receptors and involves protein interactions directly associated with the AMPA receptor subunits, particularly GluR2 (Collingridge et al., 2004; Malinow and Malenka, 2002) . We reasoned that GSK3b might form a complex with AMPA receptors, and thus sought to investigate this by probing for an association of native GSK3b with AMPA receptors in the CA1 area of hippocampal slices. A specific antibody against GSK3b was able to coimmunoprecipitate the GluR1 and GluR2 AMPA receptor subunits ( Figure 4C ), and conversely, immunoprecipitation of AMPA receptors produced coimmunoprecipitation of GSK3b ( Figure 4D ). To determine the functional status of AMPA receptor-associated GSK3b, we immunoprecipitated AMPA receptors, using antibodies against either GluR1 or GluR2, and then assayed for kinase activity. GSK3b activity was readily detected in both GluR1 and GluR2 immunoprecipitates relative to the background IgG control ( Figure 4E ), demonstrating that endogenous GSK3b associates with native AMPA receptors in the brain, and that the bound GSK3b is functionally active. This association of GSK3b with AMPA receptors suggests a compartmentalization of this enzyme for the efficient regulation of AMPA receptors during LTD.
We wondered whether the GSK3b activity that is associated with AMPA receptors could be regulated. Previous work has shown that transient exposure of cultured neurons to a solution containing sucrose plus glycine leads to an NMDA receptor-dependent insertion of AMPA receptors into the plasma membrane (Man et al., 2003) . Interestingly, this effect is associated with an increase in AMPA receptor-associated PI3K activity. Since PI3K is an upstream regulator of GSK3b, we explored whether this treatment also affected the AMPA receptorassociated GSK3b enzyme activity. Neurons were treated with sucrose (200 mM) plus glycine (100 mM) for 2 min, and this led to the insertion of AMPA receptors into the plasma membrane as determined approximately 15 min later using surface biotinylation assays (30% ± 7% increase, n = 6, p < 0.01 for GluR1; and 35% ± 8% increase, n = 11, p < 0.05 for GluR2; Figure 4F ). This chemically induced AMPA receptor insertion was associated with a decrease in AMPA receptor-associated GSK3b activity (31% ± 4% inhibition; n = 4; p < 0.05; Figure 4G ).
LTP Inhibits the Induction of LTD
The finding that LTP stimuli can inhibit GSK3b, and that GSK3b activity is required for LTD, suggests that LTP may inhibit subsequent LTD at the same set of synapses. 
Neuron
To test this idea we developed a protocol whereby the effects of a prior LTP stimulus on the induction of LTD could be examined without the complication of LTP-induced alterations in synaptic strength. For this we delivered an LTP induction protocol of 60 pulses at 0.5 Hz while the neuron was depolarized to 0 mV. This well-established ''pairing'' protocol produced a robust LTP when applied soon after commencement of a whole-cell recording ( Figure 5A ). However, when this pairing protocol was applied after more than 10 min of whole-cell dialysis, LTP did not occur ( Figure 5A ), due to the phenomenon of ''washout'' of LTP (Malinow and Tsien, 1990) . We reasoned that pairing would still drive the PI3K-Akt-GSK3b pathway following washout. This pathway is resistant to dialysis since both PI3K inhibitors (Daw et al., 2002) and GSK3b inhibitors (Figure 2 ) still affect LTD after an extended period of whole-cell recording. All our subsequent whole-cell experiments were, therefore, conducted after at least 10 min of recording to enable washout to occur. Consistent with our prediction, when pairing was delivered immediately prior to the LTD induction protocol, it completely prevented the generation of LTD ( Figure 5B ). The conditioning effect was fully reversible since the full level of LTD could be obtained if the induction protocol was delivered 1 hr following pairing ( Figure 5C ). The effect of conditioning was, however, fairly long-lasting. For example, when pairing was delivered 20 min beforehand, it still largely blocked the generation of LTD (Figures 5D and  5F ). Conditioning involved the activation of NMDA receptors since it was prevented by the NMDA receptor antagonist D-AP5 ( Figures 5E and 5F ).
Although it is unlikely that washout affected the signaling mechanisms involved in the NMDA receptor-mediated inhibition of LTD, we went on to investigate whether LTD Neuron was blocked following the production of LTP under more physiological conditions. So as not to perturb the neurons, we performed extracellular recordings and induced LTP with tetanic stimuli. An inherent complication of these experiments is that the stimulus used to induce LTD can also induce an mGluR-dependent form of depotentiation (Bortolotto et al., 1994) . To remove this additional factor, we performed these experiments in the presence of the broad spectrum metabotropic glutamate (mGlu) receptor antagonist LY341495 (100 mM), which blocks this type of depotentiation (Fitzjohn et al., 1998) . In the presence of LY341495, LFS consistently induced LTD of baseline responses (control [input 1]: 64% ± 4% of baseline; LY341495 [input 2]: 68% ± 2% of baseline; n = 3; data not illustrated). In contrast, if the same stimulation was delivered shortly after inducing LTP, then long-term synaptic depression was fully blocked ( Figure 5G ). Consistent with the reversibility of the conditioning effect, the same stimulation delivered 60 min following the induction of LTP was able to induce long-term synaptic depression ( Figure 5H ) that was dependent on the synaptic activation of NMDA receptors ( Figure 5I) . Therefore, the synaptic activation of NMDA receptors during LTP inhibits the induction of LTD for approximately 1 hr.
A Role for PI3K and Akt in the Conditioned Block of LTD Using whole-cell recordings, we next investigated whether this block of LTD by prior NMDA receptor activation was due to activation of the PI3K-Akt pathway. First we tested the role of PI3K using the selective inhibitors wortmannin (500 nM) or LY294002 (10 mM). In the presence of wortmannin, EPSCs were readily evoked, and pairing alone, after LTP washout, had no effect on transmission ( Figure 6A ). Treatment with wortmannin also had no effect on the amount of LTD induced ( Figure 6B ). However, wortmannin completely prevented the block of LTD by the LTP pairing stimulus ( Figure 6C ). LY294002 had the same effect; it also completely prevented the effect of the prior conditioning on LTD ( Figure 6D ). Thus, using two structurally unrelated inhibitors, our data indicate that PI3K is required for the NMDA receptor-dependent inhibition of LTD. An alternative mechanism for inhibition of GSK3b may be via the mammalian target of rapamycin (mTOR) pathway (Frame and Cohen, 2001 ). However, inhibition of mTOR using rapamycin did not affect conditioning ( Figure 6E ). A possible alternative explanation for this result is that rapamycin directly blocks LTD. However, LTD was readily induced in the presence of rapamycin if the conditioning pairing stimulus was not delivered ( Figure 6F ). Thus, NMDA receptor-dependent inhibition of LTD involves the PI3K, but not the mTOR, pathway.
As discussed above, our data suggest that the PI3K-Akt-GSK3b pathway operates normally in whole-cell recording experiments regardless of washout of LTP. However, we further confirmed the involvement of PI3K in the synaptic inhibition of long-term synaptic depression under circumstances in which LTP was induced. To do this, we again performed extracellular recording experiments in the presence of a broad spectrum mGluR antagonist to block mGluR-dependent depotentiation. We performed two-input experiments and (1) induced LTP and then tested for long-term synaptic depression in the presence of a reversible PI3K inhibitor, and (2) applied these same protocols to the second input after washout of the PI3K inhibitor. The results after washout of LY294002 were the same as those for the control experiments (illustrated in Figure 5G ) and show that LTP blocks long-term synaptic depression ( Figure 6G ). In contrast, long-term synaptic depression is readily induced in the presence of LY294002 ( Figure 6G ). This is due to block of conditioning rather than an effect of LY294002 on LTP per se, since, in interleaved experiments, LY294002 did not affect LTP induced by four tetani ( Figure 6H ) (see also Horwood et al., 2006) .
Using whole-cell recording, we next investigated whether Akt is involved in this process using three complementary strategies ( Figure 7A ). First, we used a peptide (TCS 183) that mimics the Akt phosphorylation site on GSK3b. Inclusion of this false substrate at a concentration of 300 mM in the patch electrode solution prevented the effect of conditioning ( Figure 7B ). Next we used a construct containing just the pleckstrin homology (PH) domain of Akt, since this acts as a highly specific inhibitor of Akt within this signaling pathway . In interleaved blind experiments, GST-PH-Akt ( Figure 7D ), but not GST alone ( Figure 7C ), also blocked conditioning. Finally, we examined the effects of an antibody that inhibits the function of Akt (Hill et al., 1999) . This antibody also inhibited the conditioning effect ( Figure 7F ). In contrast, the same antibody when heat-inactivated proved ineffective at blocking conditioning ( Figure 7E ), as did an antibody against mTOR (99% ± 3% of control; n = 4; data not illustrated). These experiments demonstrate the essential role of Akt in the conditioning blockade of LTD. Collectively, these experiments demonstrate that the transient activation of NMDA receptors during LTP inhibits subsequent LTD via the PI3K-Akt-GSK3b pathway.
DISCUSSION
In the present study we have identified a form of regulation of synaptic plasticity in which the transient synaptic activation of NMDA receptors, as occurs during LTP, leads to inhibition of LTD. This regulation is very powerful since LTD is fully inhibited immediately following the conditioning stimulus and the effect lasts for approximately 1 hr. We have also identified some of the signaling pathways responsible for this potent regulation of synaptic plasticity. We have found that GSK3b activity is an absolute requirement for the induction of LTD and that the conditioning stimulus inhibits its activity via activation of the PI3K-Akt pathway. Finally, we show that there is a correlation between the phosphorylation state of GSK3b ser9 and whether NMDA receptor activation leads to the induction or inhibition of LTD. This new regulatory mechanism is shown schematically in Figure 8 .
A Function for GSK3b in the CNS
GSK3b is an unusual kinase that has been implicated in many diseases. However, very little is known about its normal function in the nervous system. It is important during early development and it has been shown to play a key role in cell polarity (Etienne-Manneville and Hall, 2003) and in the growth of neuromuscular junctions (Franco et al., 2004) . Recently, it has been shown that GSK3b is important for determining neuronal polarity during the development of hippocampal neurons (Jiang et al., 2005; Yoshimura et al., 2005) . However, though GSK3b is also highly expressed in the mature brain (Woodgett, 1990) , its function in the nervous system has, hitherto, been largely unexplored. In the nucleus of hippocampal neurons, GSK3b is involved in the regulation of gene transcription by promoting the nuclear export of the transcription factor NF-ATc4 (Graef et al., 1999) . In addition, it has been shown that overexpression of GSK3b impairs spatial learning (Hernandez et al., 2002) , though the mechanism underlying this effect is unknown. Here we show that in 2-week-old rats, an age at which the expression of GSK3b is near its peak (Takahashi et al., 2000) , GSK3b activity is essential for NMDA receptor-dependent LTD in the hippocampus. This form of LTD is widespread throughout the brain and has been strongly implicated in development and learning and memory Kemp and Bashir, 2001) . Therefore, this novel GSK3b-dependent mechanism may be of general significance in regulating the interaction between LTP and LTD throughout the brain. (A) Wortmannin (500 nM) has no effect on the conditioning train (n = 3). (B) Wortmannin has no effect on LTD (n = 5). (C) Wortmannin completely prevents the conditioning of LTD (n = 9). (D) LY294002 (10 mM) completely prevents the conditioning of LTD (n = 6). (E) Rapamycin (0.1 mM) has no effect on conditioning (n = 4). (F) Rapamycin has no effect on LTD (n = 5). (G) Prior induction of LTP did not inhibit long-term synaptic depression when the experiment was performed in the presence of LY294002 (10 mM). Following washout of LY294002, the block of long-term synaptic depression by LTP was invariably observed (tested on an independent input; n = 5). (H) LY294002 (10 mM) did not affect the generation of LTP (n = 4).
Activation of GSK3b during LTD GSK3b, unlike most enzymes, possesses high basal level constitutive activity and can be bidirectionally regulated to either further increase or decrease its activity. Our experiments show that during LTD there is additional activation of GSK3b, probably via dephosphorylation of ser9. We show further that this effect is prevented by an inhibitor of PP1/PP2A. This suggests that the activation of PP1, which is known to occur during LTD (Mulkey et al., 1993) , is responsible for the activation of GSK3b, via its The activity of GSK3b determines whether NMDA receptor activation induces LTD or inhibits LTD. During LTD, activation of PP1 leads to dephosphorylation of GSK3b at ser9 to further activate GSK3b and enable LTD to occur. PP1 also inhibits Akt. During LTP, activation of NMDA receptors leads to stimulation of the PI3K-Akt pathway, which phosphorylates GSK3b at ser9 to inhibit its activity and prevent the induction of LTD. Thus, GSK3b, under the control of Akt and PP1, is a critical determinant of the direction of NMDA receptor-dependent plasticity.
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Neuron dephosphorylation of ser9 (Lee et al., 2005; Morfini et al., 2004; Szatmari et al., 2005) . We also show that LTD is associated with inhibition of Akt, probably also via the activation of PP1. These data suggest that GSK3b activity is increased during LTD because the phosphatase concomitantly inhibits Akt and directly dephosphorylates ser9 of GSK3b.
Interestingly, the alteration in the phosphorylation status of GSK3b persisted beyond the delivery of LFS, and lithium completely blocked LTD when applied after the delivery of LFS. These data suggest that GSK3b is required for the LTD process beyond the initial induction phase. Further studies are required to determine the full time course of the involvement of GSK3b in LTD.
Signaling Pathways Involved in the Actions of GSK3b
GSK3b has several upstream regulators and numerous downstream targets. In the present study, we have identified two of its upstream regulators. During LTD, GSK3b is activated via an okadaic acid-sensitive protein phosphatase, which is probably PP1 (Mulkey et al., 1993; Szatmari et al., 2005) . During LTP, GSK3b is inhibited via the PI3K-Akt pathway. Since GSK3b is such a ubiquitous kinase, it needs mechanisms to localize its access to its substrates. This is achieved in part via direct interactions with other proteins to form complexes. For example, in the canonical Wnt pathway, GSK3b binding proteins control access of b-catenin (Jope and Johnson, 2004) . It seems likely that the association between GSK3b and AMPA receptors serves to localize the kinase close to substrates that are involved in the trafficking of these receptors during synaptic plasticity. Further studies are required to establish the mechanism of this interaction as well as the downstream pathways mediated by GSK3b in the regulation of LTD.
The finding that the synaptic activation of NMDA receptors during LTP inhibits NMDA receptor-dependent LTD raises an intriguing issue: what determines whether the synaptic activation of NMDA receptors leads to the induction or inhibition of LTD? We present evidence that the phosphorylation state of ser9 of GSK3b is a critical determinant. Thus, during LTP, activation of the PI3K-Akt pathway results in phosphorylation of GSK3b, and hence inhibition of its activity. In contrast, during LTD, activation of PP1 results in inhibition of Akt and the dephosphorylation of GSK3b at ser9, and this leads to an increase in the enzyme's activity. The activation of PI3K-Akt (Man et al., 2003) and inhibition of PP1 (Atkins et al., 2005) during LTP, but inhibition of Akt during LTD (the present study) as well as the selective activation of PP1 during LTD (Mulkey et al., 1993) , can be explained by the differences in the magnitude and spatiotemporal properties of the Ca 2+ rise associated with the synaptic activation of NMDA receptors during these two forms of synaptic plasticity.
GSK3b-Mediated Metaplasticity
Previous work (e.g., Huang et al., 1992; Montgomery and Madison, 2002) has described other ways in which synaptic plasticity can be powerfully influenced by the prior history of synaptic activity. However, the mechanisms involved in these forms of metaplasticity are not known. Why synapses need such regulatory mechanisms is a matter of conjecture. One intriguing possible role for the regulation described here is to stabilize a synaptic modification over the short term by protecting synapses from the effects of additional NMDA receptor-dependent plasticity until the information can be either consolidated or erased by NMDA receptor-independent mechanisms. The regulation of synaptic plasticity is further complicated by the involvement of mGluRs, which are involved in depotentiation (Bortolotto et al., 1994) , LTD of baseline transmission (Bolshakov and Siegelbaum, 1994) , heterosynaptic LTD (Daw et al., 2002) , and metaplasticity (Abraham and . So that we could focus on interactions between the NMDA receptor-dependent forms of synaptic plasticity, we eliminated the additional complication of mGluR-dependent synaptic plasticity by using the broad spectrum mGluR antagonist LY341495 and by employing stimulus protocols optimized for NMDA receptordependent synaptic plasticity. However, given that PI3K has been implicated in a chemically induced form of mGluR-dependent LTD (Hou and Klann, 2004 ) and heterosynaptic LTD (Daw et al., 2002) , it will be interesting to determine whether GSK3b is also involved in these forms of synaptic plasticity. One possibility is that the PI3K-AktGSK3b pathway serves to inhibit NMDA receptor-dependent LTD both homosynaptically following the induction of LTP and heterosynaptically following the induction of LTD.
Clinical Implications
Our finding that in the normal brain activation of GSK3b is essential for NMDA receptor-dependent LTD, and that its activity can be regulated by LTP, may offer clues to the pathological role of this enzyme in neurological disorders. For example, the primary therapeutic action of lithium in bipolar disorders may be via inhibition of GSK3b (Grimes and Jope, 2001; Klein and Melton, 1996) . Indeed, specific inhibition of GSK3b has recently been shown to produce antidepressive-like activity in vivo (Kaidanovich-Beilin et al., 2004) . Overactivity of GSK3b may, therefore, lead to this mood disorder by affecting the balance and interplay between NMDA receptor-dependent LTP and LTD.
EXPERIMENTAL PROCEDURES
General Antibodies and Reagents
Rabbit anti GSK3b was obtained from Santa Cruz. Rabbit phosphoGSK3b (ser9); mouse monoclonal antibody (mAb) Akt1 and rabbit mAb phospho-Akt (thr308) were obtained from Cell Signaling Technology (Beverly, MA). Mouse mAb MAP2 was obtained from BD Pharmagen (San Diego, CA). ProLong Gold mounting medium and secondary fluorophore-bound IgGs (Alexa Fluor series) for immunocytochemistry were obtained from Invitrogen-Molecular Probes (Portland, OR). Rabbit IgG, recombinant rat GSK3b, and phosphoglycogen synthase peptide-2 were obtained from Upstate Biotechnology, Inc. (Lake Placid, NY 
Electrophysiology
Experiments were performed on 400 mm thick parasagittal hippocampal slices obtained from juvenile (13-to 15-day-old) rats, which were perfused with artificial cerebrospinal fluid (ACSF) which was comprised of the following: 124 mM NaCl, 3 mM KCl, 26 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , 2 mM CaCl 2 , 1 mM MgSO 4 , 15 mM glucose, 2 mM Ascorbate, and 0.01 mM (-)-bicuculline methochloride. In experiments in which LiCl was added to the perfusuate, the equivalent amount of NaCl was omitted from the ACSF. Visually guided, wholecell recordings were obtained at room temperature (RT) from the soma of CA1 neurons using patch electrodes that contained the following: 130 mM CsMeSO 4 , 10 mM HEPES, 8 mM NaCl, 0.5 mM EGTA, 4 mM Mg-ATP, 0.3 mM Na-GTP, and 5 mM QX-314. In experiments in which LiCl was included in the whole-cell solution, the equivalent concentration of CsMeSO 4 was removed. Some control experiments were performed in this way, but by substituting CsCl for LiCl. When antibodies were added to the whole-cell solution, the NaCl concentration was adjusted appropriately. Two independent sets of Schaffer collateral-commissural fibers were stimulated alternately, each at a frequency of 0.1 Hz, and EPSC amplitude and access resistance were recorded on-line at a holding potential of À70 mV. LTD was induced by delivering 300 pulses (at 0.75 Hz) at À40 mV to one of the two inputs. The induction of this form of LTD was completely inhibited by the NMDA receptor antagonist D-AP5 (50 mM). Kinase inhibitors were included in the patch solution. For experiments using kenpaullone or roscovitine, these were also added to the perfusate (at 10 mM). Extracellular recordings were obtained as described previously (Fitzjohn et al., 1998) . All inhibitors were added to the perfusing medium. Data were stored and analyzed using the WinLTP Program (Anderson and Collingridge, 2001 ).
Western Blotting for Alterations in GSK3b
Phosphorylation State For western blotting, 40-50 mg of the hippocampal slice lysate from each treatment condition was separated with SDS-PAGE, transferred onto a PVDF membrane, and probed with the relevant antibodies. For sequential reprobing of the same blots, the membranes were stripped of the initial primary and secondary antibodies and subjected to immunoblotting with another target antibody. Blots were developed using enhanced chemiluminescence detection (Amersham). Band intensities were quantified using NIH ImageJ software and normalized to the quantity of b-tubulin in each sample lane. LFS was comprised of delivering 900 stimuli at 1 or 3 Hz. A small region of the slice (approximately 1.25 mm 2 ) surrounding the stimulating electrode was then dissected and homogenized. Tetanic stimulation was comprised of delivering 100 stimuli at 100 Hz to three separate locations.
GSK3b Kinase Activity Assay after LTD
To measure GSK3b activity in hippocampal slices following electrodeinduced LTD (900 stimuli delivered at 3 Hz), microdissected areas of slices were solubilized and 30 mg of the lysate was used for each assay as described (Li et al., 2003) with some modifications. Briefly, the kinase reaction occurred in a 50 ml total volume containing 20 mM MOPS (pH 7.4), 25 mM b-glycerol phosphate, 5 mM EGTA, 1 mM NA 3 VO 4 , 1 mM DTT, 15 mM MgCl 2 , 100 mM cold ATP, 7.5 ml phosphoglycogen synthase peptide-2 (1 mg/ml stock solution, Upstate, NY), 30 mg whole slice lysate (10 ml in volume), or 10 ml of water as negative control, and 2.5 mCi [g-32 P]ATP. In order to take into account the contribution of the other kinases in the consumption of [g-32 P]ATP, 20 mM LiCl was added to a second set of the same samples. The reactions were incubated for 30 min at 30 C, then stopped with the addition of 50 ml of 10% H 3 PO 4 , mixed, and spotted (30 ml) on filter paper for subsequent analysis. Finally, CPM for GSK3b activity was calculated by deducting total counts from the CPM of the duplicate samples that contained LiCl.
Coimmunoprecipitation of GSKb and AMPA Receptor Complexes
Coimmunoprecipitation and western blotting were carried out as previously reported (Taghibiglou et al., 2002) . The CA1 areas of hippocampal slices from 20-day-old SD rats were microdissected and then homogenized on ice in lysis buffer [150 mM NaCl, 10 mM tris(hydroxymethyl)aminomethane (pH 7.4), 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, and 1% Nonidet P 40] containing an inhibitor cocktail (2 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 100 mM NaF, 10 mM Na pyrophosphate, and 2 mM NA 3 VO 4 ) for blocking phosphatase and protease activity. Lysates were subjected to coimmunoprecipitation for 16-18 hr at 4 C with a rabbit polyclonal antibody against GSK3b (2-10 mg of antibody/1-1.5 mg of total lysate), with rabbit polyclonal antibodies against the C terminus of either GluR1 or GluR2 (both raised in-house), or with control IgG antibodies bound to 50 ml of a 50% (w/v) protein A-sepharose bead slurry per sample. Precipitates were washed three to four times on ice with wash buffer (phosphatebuffered saline [PBS] containing 0.1% Nonidet P40, 0.1% Triton X-100 with the inhibitor cocktail) and boiled in 60 ml sample buffer for 5-10 min. Precipitates were loaded for SDS-PAGE separation and subjected to western blotting for the appropriate targets as described below.
Assay for GSK3b Associated with AMPA Receptors In order to assess any GSK3b kinase activity associated with GluR1 and GluR2 subunits of AMPA receptor, we subjected 1 mg of slice lysate to coimmunoprecipitation with either rabbit IgG (background control) or antibodies against GluR1 and GluR2. These bead-bound coimmunoprecipitates were subsequently used for GSK3b kinase assays according to the supplier's protocol (Upstate Biotechnology, Inc., Lake Placid, NY) with some modifications. Briefly, kinase activity was assayed in a total volume of 50 ml of kinase buffer containing 8 mM MOPS (pH 7.4), 10 mM MgCl 2 , 1 mM DTT, 250 mM ATP, 2 mCi of [g-32 P]ATP, and 100 mM phosphoglycogen synthase peptide-2 (YRRAAVPPSPSLSRHSSPHQSEDEEE), and incubated at 30 C for 30-60 min. Recombinant rat GSK3b (1-3 mg active kinase per assay) was used as a positive control. After pelleting the beads, 25 ml of reaction supernatant was spotted onto filter paper (Millipore, Bedford, MA) and the proteins were briefly allowed to bind the filter paper for 30 s. The filter papers were washed three times in 60-100 ml 0.75% phosphoric acid for a total time of 15 min, once more in acetone for 5 min, dried, and then counted in a liquid scintillation counter. Background subtraction was done using counts from IgG controls for each independent experiment.
GSK3b Kinase Assay Associated with AMPA Receptor Insertion GSK3b activity assays were performed on GluR2-GSK3b coimmunopreciptated lysates from cortical neurons (12-14 DIV), cultured as previously described (Man et al., 2003) . AMPA receptor insertion was induced using 200 mM sucrose plus 100 mM glycine, applied for 2 min at 37 C as previously described (Lu et al., 2001 
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A Role for GSK3b in Synaptic Plasticity before and coimmunoprecipitated for 2-4 hr at 4 C with a mouse GluR2 N-terminal monocolonal antibody (10 mg/mL; Chemicon) bound to Protein G-sepharose beads. Kinase activity was assessed on coimmunoprecipitates as described above and background subtracted using counts from IgG controls.
Immunocytochemistry
Cultured hippocampal neurons (14-17 DIV) were fixed in 4% PFA and 4% sucrose/PBS solution for 10 min, permeabilized in 0.1% Triton X-100 for 5 min, and blocked with 2% goat serum diluted in PBS for 30 min with extensive PBS washings between each step. Blockingbuffer-diluted antibodies against GSK3b (1:250) and MAP2 (1:2000) were incubated for either 1 hr at RT or overnight at 4 C. Goat-raised secondary antibodies (1:1000), rabbit Alexa 555 (for GSK3b), and mouse Alexa 488 (for MAP2) were incubated for 1 hr at RT and washed extensively in 0.5 M NaCl supplemented PBS prior to mounting on slides in ProLong Gold medium. Captured images were obtained from a Leica DMIRE2 deconvolution microscope using OpenLab software. Representative images have been adjusted to maximize the signal:noise ratio. Relative intensities from each fluorophore channel were adjusted for a 50:50 contribution of signal intensities prior to merge of the two channel images and subsequent analysis of the cellular location of neuronal GSK3b.
Preparation of Synaptosomes
Slices of cerebral cortex or hippocampus were homogenized in 10 volumes of solution containing 20 mM HEPES (pH 7.4), 0.32 M sucrose, 1 mM EDTA, 5 mM DTT, and protease/phosphatase inhibitor cocktail.
Homogenates were subjected to centrifugation at 1000 3 g max , 4 C, for 10 min. The supernatant was centrifuged at 17,000 g max at 4 C for 15 min using a SW55 Beckman rotor. The resultant pellet was resuspended in 4 ml of the abovementioned homogenization buffer and layered top to bottom with 4 ml of 0.8 M sucrose overlaid with 4 ml of 1.2 M sucrose. The gradient was centrifuged at 54,000 g max , 4 C, for 90 min, using a SWTi41 Beckman rotor. The synaptosome fraction was removed from the 0.8 M and 1.2 M sucrose interface. The collected fraction ($0.5 ml) was diluted with 10 volumes of icecold 0.32 M sucrose and centrifuged at 20,000 g max , 4 C, for 15 min, using a SW55 Beckman rotor. The resulting synaptosomal pellet was dissolved in a solubilizing buffer.
Biotin Labeling of Neuronal Surface Proteins
Cultured cortical neurons subjected to chemical LTP induction were cooled to 4 C after treatment and labeled for 30 min with sulfo-NHS-LC-Biotin (1 mg/ml). Cells were washed three times in cold phosphate-buffered saline and then harvested in lysis buffer. Lysates were subjected to overnight avidin precipitation (280 mg of total protein/60 ml of avidin suspension), washed four to five times, loaded on a gel for SDS-PAGE, and western blotted for surface AMPA receptor expression.
